Newborn Eye Imaging Systems Market (By Disease Type: ROP, Retinal Disease, Strabismus, Refractive Error, Color Blindness, Others; By Device Type: Basic Device, Wireless Device; By End User: Hospitals, Ophthalmology Diagnosis Centers, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Newborn Eye Imaging Systems Market
5.1. COVID-19 Landscape: Newborn Eye Imaging Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Newborn Eye Imaging Systems Market, By Disease Type
8.1. Newborn Eye Imaging Systems Market, by Disease Type, 2024-2033
8.1.1 ROP
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Retinal Disease
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Strabismus
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Refractive Error
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Color Blindness
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Newborn Eye Imaging Systems Market, By Device Type
9.1. Newborn Eye Imaging Systems Market, by Device Type, 2024-2033
9.1.1. Basic Device
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Wireless Device
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Newborn Eye Imaging Systems Market, By End-User
10.1. Newborn Eye Imaging Systems Market, by End-User, 2024-2033
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Ophthalmology Diagnosis Centers
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Ambulatory Surgical Centers
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Newborn Eye Imaging Systems Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.1.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.1.3. Market Revenue and Forecast, by End-User (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.1.4.3. Market Revenue and Forecast, by End-User (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.1.5.3. Market Revenue and Forecast, by End-User (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.2.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.2.3. Market Revenue and Forecast, by End-User (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.2.4.3. Market Revenue and Forecast, by End-User (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.2.5.3. Market Revenue and Forecast, by End-User (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.2.6.3. Market Revenue and Forecast, by End-User (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.2.7.3. Market Revenue and Forecast, by End-User (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.3.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.3.3. Market Revenue and Forecast, by End-User (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.3.4.3. Market Revenue and Forecast, by End-User (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.3.5.3. Market Revenue and Forecast, by End-User (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.3.6.3. Market Revenue and Forecast, by End-User (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.3.7.3. Market Revenue and Forecast, by End-User (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.4.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.4.3. Market Revenue and Forecast, by End-User (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.4.4.3. Market Revenue and Forecast, by End-User (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.4.5.3. Market Revenue and Forecast, by End-User (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.4.6.3. Market Revenue and Forecast, by End-User (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.4.7.3. Market Revenue and Forecast, by End-User (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.5.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.5.3. Market Revenue and Forecast, by End-User (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.5.4.3. Market Revenue and Forecast, by End-User (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Disease Type (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Device Type (2021-2033)
11.5.5.3. Market Revenue and Forecast, by End-User (2021-2033)
Chapter 12. Company Profiles
12.1. Visunex Medical Systems
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Eye Photo Systems
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. MergeHealthcare
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. D-EYE
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Imagine Eyes
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Natus Medical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Servicom Medical
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample